(Q53402158)

14 May 2018

title

Nocodazole is a high-affinity ligand for the cancer-related kinases ABL, c-KIT, BRAF, and MEK. (English)

1 reference

14 May 2018

main subject

nocodazole

1 reference

ChEBI release 2020-05-28

3

Sungwoo Hong

1 reference

14 May 2018

author name string

Hwangseo Park

series ordinal

1

1 reference

14 May 2018

Seunghee Hong

series ordinal

2

1 reference

14 May 2018

publication date

14 October 2011

1 reference

14 May 2018

published in

ChemMedChem

1 reference

14 May 2018

volume

7

1 reference

14 May 2018

issue

1

1 reference

14 May 2018

page(s)

53-56

1 reference

14 May 2018

Nocodazole, a microtubule de-polymerising agent, induces apoptosis of chronic lymphocytic leukaemia cells associated with changes in Bcl-2 phosphorylation and expression

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100410

Nocodazole inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes via a microtubule-independent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100410

Nocodazole-induced p53-dependent c-Jun N-terminal kinase activation reduces apoptosis in human colon carcinoma HCT116 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100410

Nocodazole-induced changes in microtubule dynamics impair the morphology and directionality of migrating medial ganglionic eminence cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100410

Phosphoproteomic analysis of distinct tumor cell lines in response to nocodazole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100410

The Abl family kinases: mechanisms of regulation and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100410

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100410

AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100410

Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100410

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100410

Detection of the c-kit D816V mutation in systemic mastocytosis by allele-specific PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100410

Prediction of molecular solvation free energy based on the optimization of atomic solvation parameters with genetic algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100410

Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100410

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CMDC.201100410

1 reference

14 May 2018

1 reference

14 May 2018